Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 541 to 555 of 1284 results for social care

  1. Methods research areas

    NICE priority methodological research areas.

  2. Support a quality standard

    reference panel membership Meetings in public Consultations GPs and primary care NICE training and development opportunities By...

  3. Support a quality standard

    reference panel membership Meetings in public Consultations GPs and primary care NICE training and development opportunities By...

  4. Purchasing steps: direct awards

    A guide to the steps to follow when buying sole supplied titles from Lot 1 of our purchasing framework.

  5. Implementation help and advice

    NICE work with the NHS, patients and carers, healthcare professionals and organisations to help put our guidance into practice.

  6. Givinostat for treating Duchenne muscular dystrophy in people 6 years and over [ID6323]

    In development Reference number: GID-TA11373 Expected publication date: TBC

  7. Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosis [ID6487]

    In development Reference number: GID-TA11628 Expected publication date: TBC

  8. Meetings in public

    Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.

  9. Meetings in public

    Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.

  10. Learning disabilities: health checks and action plans (IND265)

    This indicator covers the percentage of patients on the learning disability register who received a learning disability health check and had a completed health action plan in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM249

  11. NICE and virtual wards

    We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.

  12. Prioritisation board decisions 2026

    Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.

  13. About indicators

    Our indicators measure outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.

  14. Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancer [ID6177]

    In development Reference number: GID-TA11140 Expected publication date: TBC

  15. Tafasitamab with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma after 1 or more systemic treatments [ID6413]

    In development Reference number: GID-TA11488 Expected publication date:  15 July 2026